A Double Blind Randomized Placebo Controlled Study To Evaluate the Efficacy Safety and Pharmacodynamics of AT1001 in Patients with Fabry Disease and AT1001 Responsive GLA Mutations

---

Ezgü F. S. (Executive), Tümer L., İnci A., Okur İ.

Industrial Organizations of Other Countries Supported Project, 2009 - 2014

• Project Type: Industrial Organizations of Other Countries Supported Project
• Begin Date: August 2009
• End Date: January 2014